Menu

Speaking of Science

May 2013's selection of notable quotes

May 1, 2013
The Scientist Staff

PHOTO BY J. CAMERON/WIKIMEDIA COMMONS

At last gleams of light have come,
& I am almost convinced (quite
contrary to opinion I started with)
that species are not (it is like
confessing a murder) immutable.

—Naturalist Charles Darwin, in a letter to friend and colleague Joseph Hooker, one of many pieces of correspondence between the two biologists that were recently made available online for the first time (January 11, 1844)

This financial stress on institutions comes at a really tough time. It has a chilling effect on what was already a chilly situation.

Debra Stewart, president of the Council of Graduate Schools, discussing the effects of sequestration on enrollment in US graduate schools (April 3)

This initiative is a boost for the brain
like the Human Genome Project was
for the genes. This is the start of the
million neuron march.

Terrence Sejnowski, neuroscientist at the
Salk Institute for Biological Studies, on the recently announced Brain Research
through Advancing Innovative Neurotechnologies (BRAIN) Initiative,
to which $100 million is devoted in President Barack Obama’s 2014
budget proposal (April 2)

One of the wonderful things about transgenesisis that we can do all at once what evolution has taken million of years to do.

—Yale University geneticist Francis Ruddle, who produced the first transgenic mouse using viral DNA in 1980 and died on March 10, as quoted in his New York Times obituary (March 20)

Most of the experiments we do are irrelevant . . . . We’re not going to cure cancer by doubling the money. We’re going to do it by being more intelligent. The money thing is just a red herring of people not thinking.

— Biologist and Nobel Laureate James Watson, in remarks after a recent public lecture on the role of antioxidants in cancer at the University of California, San Diego (March 21)

You should take all elderly scientists with a grain of salt—including me.

—Biochemist and Nobel Laureate Roger Tsien, in reply to questions about a tense exchange he had with Watson at the UC San Diego lecture (March 21)

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!